Stocks & Options
Trading Strategies
Institutional Ownership
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
ALZAMEND NEURO, INC. Reports Q3 2026 Financial Results
2026-03-11
SEC Filing 10-Q
(0001214659-26-003166)
Please check the link below for details.
Ticker mentioned:
ALZN
Source:
Original SEC Document β